神经酰胺在非酒精性脂肪性肝病发生发展中的作用

韩海静; 齐雪; 牛春燕

doi:10.3969/j.issn.1001-5256.2017.08.038

神经酰胺在非酒精性脂肪性肝病发生发展中的作用

DOI: 10.3969/j.issn.1001-5256.2017.08.038

1. 西安医学院
2. 西安医学院第一附属医院

基金项目:

基金项目:陕西省优势学科(陕教位[2014]3号文件)；

详细信息

中图分类号: R575.5
计量
- 文章访问数: 2283
- HTML全文浏览量: 24
- PDF下载量: 470
- 被引次数: 0
出版历程
- 收稿日期: 2017-01-22
- 出版日期: 2017-08-20

Role of ceramide in development and progression of nonalcoholic fatty liver disease

Xi'an Medical University

Research funding:

摘要

摘要: 非酒精性脂肪性肝病(NAFLD)是除外酒精和其他明确的肝损害因素所致的,以弥漫性肝细胞大泡性脂肪变为主要特征的临床病理综合征。"二次打击"学说可以部分解释NAFLD的发病机制。神经酰胺是NAFLD发生发展中关键的分子信使,而且其作为一种鞘脂与"二次打击学说"密切相关。对神经酰胺在NAFLD中的作用进行了综述。
- 脂肪肝 /
- 神经酰胺类 /
- 综述
Abstract: Nonalcoholic fatty liver disease ( NAFLD) is a clinicopathological syndrome caused by liver damage factors except alcohol and has the major feature of diffuse macrovesicular hepatocyte steatosis. The " two-hit " hypothesis can partly explain the pathogenesis of NAFLD. Recent studies have found that ceramide is a key molecular messenger involved in the development and progression of NAFLD, and as a sphingolipid, it is closely associated with the " two-hit" hypothesis. This article reviews the role of ceramide in NAFLD.
- fatty liver /
- ceramides /
- review

HTML全文

参考文献(46)

[1]WANG FG, LIANG WF, XI JJ, et al.Establishment and applications of non-alcoholic steatohepatitis animal models[J].Chin J Clin Pharmacol Ther, 2015, 20 (7) :835-840. (in Chinese) 王福根, 梁伟峰, 席建军, 等.非酒精性脂肪性肝炎动物模型的建立与应用[J].中国临床药理学与治疗学, 2015, 20 (7) :835-840.

[2]LI J, YE F.Research advances in pathogenesis of nonalcoholic fatty liver disease[J].J Int Pharm Res, 2011, 38 (5) :341-344. (in Chinese) 李娟, 叶菲.非酒精性脂肪性肝病发病机制的研究进展[J].国际药学研究杂志, 2011, 38 (5) :341-344.

[3]PAGADALA M, KASUMOV T, Mc CULLOUGH AJ, et al.Role of ceramides in nonalcoholic fatty liver disease[J].Trends Endocrinol Metab, 2012, 23 (8) :365-371.

[4]LEBESGUE N, MEGYERI M, CRISTOBAL A, et al.Combining deep sequencing, proteomics, phosphoproteomics, and functional screens to discover novel regulators of sphingolipid homeostasis[J].J Proteome Res, 2017, 16 (2) :571-582.

[5]VENABLE ME.Elevation of ceramide in senescence:role of sphingolipid metabolism[J].Tumor Dormancy, 2014, 32 (2) :81-88.

[6]GONI FM, SOT J, ALONSO A, et al.Biophysical properties of sphingosine, ceramides and other simple sphingolipids[J].Biochem Soc Trans, 2014, 42 (5) :1401-1408.

[7]BIENIAS K, FIEDOROWICZ A, SADOWSKA A, et al.Regulation of sphingomyelin metabolism[J].Pharmacol Rep, 2016, 68 (3) :570-581.

[8]AIROLA MV, HANNUN YA.Sphingolipid metabolism and neutral sphingomyelinases[J].Handb Exp Pharmacol, 2013, (215) :57-76.

[9]SAFAEI A, AREFI OSKOUIE A, MOHEBBI SR, et al.Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases[J].Gastroenterol Hepatol Bed Bench, 2016, 9 (3) :158-173.

[10]FIGUERA-LOSADA M, STATHIS M, DORSKIND JM, et al.Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties[J].PLo S One, 2015, 10 (5) :e0124481.

[11]FESTUCCIA WT.Turning up the heat against metabolic syndrome and non-alcoholic fatty liver disease[J].Clin Sci (Lond) , 2017, 131 (4) :327-328.

[12]MELLS JE, FU PP, HANDY JA, et al.Daily administration of liraglutide ameliorates the deleterious effects of highfructose corn syrup and transfat feeding in C57BL6 miceimplications for NAFLD[J].Hepatology, 2010, 52 (S1) :1048a.

[13]WATT MJ, BARNETT AC, BRUCE CR, et al.Regulation of plasma ceramide levels with fatty acid oversupply:evidence that the liver detects and secretes de novo synthesised ceramide[J].Diabetologia, 2012, 55 (10) :2741-2746.

[14]LAKE AD, NOVAK P, HARDWICK RN, et al.The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease[J].Toxicol Sci, 2014, 137 (1) :26-35.

[15]XIA JY, HOLLAND WL, KUSMINSKI CM, et al.Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis[J].Cell Metab, 2015, 22 (2) :266-278.

[16]de la MAZA MP, RODRIGUEZ JM, HIRSCH S, et al.Skeletal muscle ceramide species in men with abdominal obesity[J].J Nutr Health Aging, 2015, 19 (4) :389-396.

[17]GALADARI S, RAHMAN A, PALLICHANKANDY S, et al.Role of ceramide in diabetes mellitus:evidence and mechanisms[J].Lipids Health Dis, 2013, 12:98.

[18]KAKAZU E, MAUER AS, YIN M, et al.Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner[J].J Lipid Res, 2016, 57 (2) :233-245.

[19]PARK K, IKUSHIRO H, SEO HS, et al.ER stress stimulates production of the key antimicrobial peptide, cathelicidin, by forming a previously unidentified intracellular S1P signaling complex[J].Proc Natl Acad Sci U S A, 2016, 113 (10) :e1334-e1342.

[20]HUANG S, WANG J, WANG L.Knockdown of Sucla2 decreases the viability of mouse spermatocytes by inducing apoptosis through injury of the mitochondrial function of cells[J].Folia Histochem Cytobiol, 2016, 54 (3) :134-142.

[21]KOGOT-LEVIN A, SAADA A.Ceramide and the mitochondrial respiratory chain[J].Biochimie, 2014, 100:88-94.

[22]LI PL, ZHANG Y.Cross talk between ceramide and redox signaling:implications for endothelial dysfunction and renal disease[J].Handb Exp Pharmacol, 2013, 216:171-197.

[23]GALBO T, PERRY RJ, JURCZAK MJ, et al.Saturated and unsaturated fat induce hepatic insulin resistance independently of TIR4signaling and ceramide synthesis in vivo[J].Proc Natl Acad Sci U S A, 2013, 110 (31) :12780-12785.

[24]CORRIDEN R, HOLLANDS A, OLSON J, et al.Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramide[J].Nat Commun, 2015, 6:8369.

[25]HSIEH CT, CHUANG JH, YANG WC, et al.Ceramide inhibits insulin-stimulated Akt phosphoryl ation through activation of Rheb/m TORC1/S6K signaling in skeletal muscle[J].Cell Signal, 2014, 26 (7) :1400-1408.

[26]BRITTON LJ, SUBRAMANIAM VN, CRAWFORD DH.Iron and non-alcoholic fatty liver disease[J].World J Gastroenterol, 2016, 22 (36) :8112-8122.

[27]MARTINELLI N, TRAGLIA M, CAMPOSTRINI N, et al.Increased serum hepcidin levels in subjects with the metabolic syndrome:a population study[J].PLo S One, 2012, 7 (10) :e48250.

[28]ALKHATEEB AA, BUCKETT PD, GARDECK AM, et al.The small molecule ferristatin II induces hepatic hepcidin expression in vivo and in vitro[J].Am J Physiol Gastrointest Liver Physiol, 2015, 308 (12) :g1019-g1026.

[29]CHAURASIA B, KADDAI VA, LANCASTER GI, et al.Adipocyte ceramides regulate subcutaneous adipose browning, inflammation, and metabolism[J].Cell Metab, 2016, 24 (6) :820-834.

[30]LU S, NATARAJAN SK, MOTT JL, et al.Ceramide induces human hepcidin gene transcription through JAK/STAT3 pathway[J].PLo S One, 2016, 11 (1) :e0147474.

[31]LANG E, BISSINGER R, GULBINS E, et al.Ceramide in the regulation of eryptosis, the suicidal erythrocyte death[J].Apoptosis, 2015, 20 (5) :758-767.

[32]ZHANG QJ, HOLLAND WL, WILSON L, et al.Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the e NOS-Akt complex[J].Diabetes, 2012, 61 (7) :1848-1859.

[33]BOON J, HOY AJ, STARK R, et al.Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance[J].Diabetes, 2013, 62 (2) :401-410.

[34]GARBUZENKO DV, AREFYEV NO, BELOV DV.Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis[J].World J Hepatol, 2016, 8 (16) :665-672.

[35]WIESNER P, LEIDL K, BOETTCHER A, et al.Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry[J].J Lipid Res, 2009, 50 (3) :574-585.

[36]KASUMOV T, LI L, LI M, et al.Ceramide as a mediator of nonalcoholic fatty liver disease and associated atherosclerosis[J].PLo S One, 2015, 10 (5) :e0126910.

[37]LIAO L, ZHOU Q, SONG Y, et al.Ceramide mediates ox-LDL-induced human vascular smooth muscle cell calcification via p38mitogen-activated protein kinase signaling[J].PLo S One, 2013, 8 (12) :e82379.

[38]ZHAO M, PAN W, SHI RZ, et al.Acid sphingomyelinase mediates oxidized-LDL induced apoptosis in macrophage via endoplasmic reticulum stress[J].J Atheroscler Thromb, 2016, 23 (9) :1111-1125.

[39]ORDOEZ R, FERNNDEZ A, PRIETO-DOMNGUEZ N, et al.Ceramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells[J].J Pineal Res, 2015, 59 (2) :178-189.

[40]JAZVINC'AK JEMBREK M, HOF PR, IMIC'G, et al.Ceramides in Alzheimer's disease:key mediators of neuronal apoptosis induced by oxidative stress and Aβaccumulation[J].Oxid Med Cell Longev, 2015, 2015:346783.

[41]TIRODKAR TS, LU P, BAI A, et al.Expression of ceramide synthase 6 transcriptionally activates acid ceramidase in a c-Jun Nterminal kinase (JNK) -dependent manner[J].J Biol Chem, 2015, 290 (21) :13157-13167.

[42]EDELMANN B, BERTSCH U, TCHIKOV V, et al.Caspase-8and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes[J].EMBO J, 2011, 30 (2) :379-394.

[43]CASTRO BM, PRIETO M, SILVA LC.Ceramide:a simple sphingolipid with unique biophysical properties[J].Prog Lipid Res, 2014, 54:53-67.

[44]NAKAJIMA K, TERAO M, TAKAISHI M, et al.Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model[J].J Invest Dermatol, 2013, 133 (11) :2555-2565.

[45]MIELKE MM, HAUGHEY NJ, HAN D, et al.The association between plasma ceramides and sphingomyelins and risk of Alzheimer's disease differs by sex and APOE in the baltimore longitudinal study of aging[J].J Alzheimers Dis, 2016.[Epub ahead of print]

[46]LEE JT, PENG GS, CHEN SY, et al.Homocysteine induces cerebral endothelial cell death by activating the acid sphingomyelinase ceramide pathway[J].Prog Neuropsychopharmacol Biol Psychiatry, 2013, 45:21-27.

施引文献

资源附件(0)

访问统计